Associated Papers
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.
Ben Dhia L et al.
Blood Cancer Journal, 2025
41136376 (PubMed )
Supplement: 41408_2025_1392_MOESM2_ESM.pdf
Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.
Newman S et al.
Cancer Discovery, 2021
34301788 (PubMed )
Supplement: cd-20-1631_supplementary_tables_suppst1.xlsx › S2.Somatic_Findings_Summary
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
Takahashi K et al.
Nature Communications, 2018
29991687 (PubMed )
Supplement: 41467_2018_4924_MOESM1_ESM.pdf
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
Maslah N et al.
Leukemia, 2017
LNK mutations and myeloproliferative disorders.
McMullin MF et al.
American Journal of Hematology, 2016
Role of the adaptor protein LNK in normal and malignant hematopoiesis.
Gery S et al.
Oncogene, 2013
The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.
Velazquez L
Archivum Immunologiae Et Therapiae Experimentalis, 2012
[Classification for myeloproliferative neoplasms and function of novel mutations].
Kirito K
[rinsho Ketsueki] the Japanese Journal of Clinical Hematology, 2011
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.
Pardanani A et al.
Leukemia, 2010
Select a paper to view details